Ewing sarcoma is the second most common highly malignant primary bone tumour of childhood after osteosarcoma, typically arising from medullary cavity with invasion of Haversian system.
#sarcoma, #bonetumor, #Ewingsarcoma #Onlydoctors #MedicalNews #BirSebebiVar #medicinanatural #EzberlerinÖtesinde #knowledge #FirstAidTips #DoctorsDemo #MayDay #MucizeDoktor #GoodDoctor

This story is of Mr. Saddam Khan from Rajasthan who was diagnosed with Ewing's Sarcoma with lung and lymph nodes. After opting for Cancer Healer Center's Immunotherapy treatment, in just 3 months his lesion size has reduced from 11cm to 4cm.

He underwent chemotherapy for 2 months but got no relief. His condition was worsening day by day when one final day he got to know about Dr. Tarang Krishna through Internet.

He opted for Immunotherapy - a painless mode of cancer treatment, and now the reports are completely normal.

He feels fortunate and is glad to receive all the care and medication from Cancer Healer Center.

#BeatCancer #Cancer #EwingSarcoma #Immunotherapy #Testimonial

Rimas J. Orentas, PhD, Seattle Children's Research Institute, Seattle, WA, discusses the development of chimeric antigen receptor (CAR) T-cell therapies targeted against IL1RAP for the treatment of Ewing's sarcoma. Preliminary studies of IL1RAP CAR-T in vivo indicated that novel approaches to enhancing efficacy are necessary. Furthermore, the role of the microenvironment and its impact on CAR-T cell therapy requires further investigation. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Dimosthenis Andreou, MD, orthopedic oncologist, University Hospital Münster, discusses prognostic factors influencing local control in Ewing sarcoma.

Over 300 international participants attended the scientific meeting “100 years Ewing Sarcoma: Learnings from the past, Challenges for the future”.

Over the course of the two-day conference December 10/11, 2021, we took a look on what has been achieved in Ewing Sarcoma so far, what the Status Quo of Ewing management currently is and where the future might take us.

The meeting was held to honor the “Cancer Man” James Ewing, who did not only describe the “Ewing Sarcoma” but was a founder of what is today the American Cancer Society and laid the foundation of today`s Memorial Sloan Kettering Cancer Centre. He was an oncologist by heart. This meeting was a great opportunity to come together and reflect upon the past in Ewing Sarcoma but also look towards the future as a global community.

This is a orthopedic teaching video from orthopedic medical students on trauma or elective orthopedic surgery and relevant topics. These videos have been created by and for our medical students from the University of Cape Town in South Africa.